Abstract
Manipulation of gene expression in developing or in mature central nervous systems (CNS) holds a promise for the resolution of many compelling neurobiological questions, including the feasibility of gene therapy to treat diseases of the brain. In this context, a number of viral vectors have been used in recent years to introduce and express genes into the CNS. This article discusses a gene transfer system based on the Herpes Simplex Virus-1 (HSV-1). We describe here the use of non-replicating, non-toxic HSV-1 vector, 8117/43, in a series of studies carried in our joint program. This vector proves further the utility of HSV-1 as a delivery vehicle to a number of distinct sites within the CNS.
| Original language | English |
|---|---|
| Pages (from-to) | 221-232 |
| Number of pages | 12 |
| Journal | Folia Morphologica |
| Volume | 59 |
| Issue number | 4 |
| State | Published - 2000 |
Keywords
- β-galactosidase
- Gene therapy
- Herpes Simplex Virus-1
- Hippocampus
- Substantia nigra
Fingerprint
Dive into the research topics of 'Gene transfer into the central nervous system using Herpes Simplex Virus-1 vectors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver